You are not logged in.
Openly accessible

Engaging community pharmacists in the primary prevention of cardiovascular disease : protocol for the pharmacist assessment of adherence, risk and treatment in cardiovascular disease (PAART CVD) pilot study

Mc Namara, Kevin P., George, Johnson, O'Reilly, Sharleen L., Jackson, Shane L., Peterson, Gregory M., Howarth, Helen, Bailey, Michael J., Duncan, Gregory, Trinder, Peta, Morabito, Elizabeth, Finch, Jill, Bunker, Stephen J., Janus, Edward, Emery, Jon and Dunbar, James A. 2010, Engaging community pharmacists in the primary prevention of cardiovascular disease : protocol for the pharmacist assessment of adherence, risk and treatment in cardiovascular disease (PAART CVD) pilot study, BMC health services research, vol. 10, pp. 264-280, doi: 10.1186/1472-6963-10-264.

Attached Files
Name Description MIMEType Size Downloads
biomedcentral-license.pdf BioMed Central License application/pdf 44.54KB 61
mcnamara-engagingcommunity-2010.pdf Published version application/pdf 219.77KB 77

Title Engaging community pharmacists in the primary prevention of cardiovascular disease : protocol for the pharmacist assessment of adherence, risk and treatment in cardiovascular disease (PAART CVD) pilot study
Author(s) Mc Namara, Kevin P.ORCID iD for Mc Namara, Kevin P. orcid.org/0000-0001-6547-9153
George, Johnson
O'Reilly, Sharleen L.ORCID iD for O'Reilly, Sharleen L. orcid.org/0000-0003-3547-6634
Jackson, Shane L.
Peterson, Gregory M.
Howarth, Helen
Bailey, Michael J.
Duncan, Gregory
Trinder, Peta
Morabito, Elizabeth
Finch, Jill
Bunker, Stephen J.
Janus, Edward
Emery, Jon
Dunbar, James A.ORCID iD for Dunbar, James A. orcid.org/0000-0003-0866-4365
Journal name BMC health services research
Volume number 10
Start page 264
End page 280
Total pages 17
Publisher BioMed Central Ltd.
Place of publication London, England
Publication date 2010-09-07
ISSN 1472-6963
Summary Background: Cardiovascular disease (CVD) is the leading cause of death globally. Community pharmacist intervention studies have demonstrated clinical effectiveness for improving several leading individual CVD risk factors. Primary prevention strategies increasingly emphasise the need for consideration of overall cardiovascular risk and concurrent management of multiple risk factors. It is therefore important to demonstrate the feasibility of multiple risk factor management by community pharmacists to ensure continued currency of their role.
Methods/Design: This study will be a longitudinal pre- and post-test pilot study with a single cohort of up to 100 patients in ten pharmacies. Patients aged 50-74 years with no history of heart disease or diabetes, and taking antihypertensive or lipid-lowering medicines, will be approached for participation. Assessment of cardiovascular risk, medicines use and health behaviours will be undertaken by a research assistant at baseline and following the intervention (6 months). Validated interview scales will be used where available. Baseline data will be used by accredited medicines management pharmacists to generate a report for the treating community pharmacist. This report will highlight individual patients’ overall CVD risk and individual risk factors, as well as identifying modifiable
health behaviours for risk improvement and suggesting treatment and behavioural goals. The treating community pharmacist will use this information to finalise and implement a treatment plan in conjunction with the patient and their doctor. Community pharmacists will facilitate patient improvements in lifestyle, medicines adherence, and medicines management over the course of five counselling sessions with monthly intervals. The primary outcome will be the change to average overall cardiovascular risk, assessed using the Framingham risk equation.
Discussion: This study will assess the feasibility of implementing holistic primary CVD prevention programs into community pharmacy, one of the most accessible health services in most developed countries.
Notes “This is an open access article distributed under the terms of the attached BioMed Central License. See attached license for details.”
Language eng
DOI 10.1186/1472-6963-10-264
Field of Research 111799 Public Health and Health Services not elsewhere classified
Socio Economic Objective 920412 Preventive Medicine
HERDC Research category C1 Refereed article in a scholarly journal
HERDC collection year 2010
Copyright notice ©2010, Mc Namara et al; licensee BioMed Central Ltd.
Persistent URL http://hdl.handle.net/10536/DRO/DU:30030424

Connect to link resolver
 
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.

Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 11 times in TR Web of Science
Scopus Citation Count Cited 13 times in Scopus
Google Scholar Search Google Scholar
Access Statistics: 591 Abstract Views, 138 File Downloads  -  Detailed Statistics
Created: Thu, 07 Oct 2010, 11:03:24 EST by Liz Jackway

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.